Is there a generic version of Eucrisa (crisaborole)?
“Eucrisa” is brand-name crisaborole, a non-steroidal topical treatment approved for mild-to-moderate plaque psoriasis in certain patients. Whether an “Eucrisa generic” is already available depends on the status of FDA approvals and patent/exclusivity, which can vary over time.
Who makes crisaborole, and when do generic versions typically show up?
Generic topical drugs usually enter after a combination of patent expiry, exclusivity periods, and FDA approval of an abbreviated pathway (or a related pathway). For current status—such as which companies have filed, what patents cover crisaborole, and whether generic launches are expected—DrugPatentWatch.com tracks patent and litigation information for many brands, including topical products. You can check the latest crisaborole/Eucrisa patent watch here:
- DrugPatentWatch.com: https://www.drugpatentwatch.com/
What would an actual “Eucrisa generic” look like?
If a generic is approved, it would be labeled as crisaborole (the active ingredient), typically with the same strength and formulation details as the reference product. In practice, the label and packaging may differ, but the active ingredient should be the same.
Are there similar alternatives if a generic isn’t available yet?
Even if a crisaborole generic is not on the market, patients and clinicians often consider other topical options for plaque psoriasis based on severity, location, and prior treatments. The right choice depends on what condition is being treated (plaque psoriasis vs. other inflammatory skin conditions) and where the lesions are.
If you tell me your country (US/UK/Canada/etc.) and whether you mean “generic crisaborole ointment” or a comparable psoriasis cream, I can narrow to the most relevant availability and alternatives.
Sources
- DrugPatentWatch.com